Targeting IL-4 receptor (IL-4R) signaling pathways emerges as a promising therapeutic avenue that offers hope for individuals dealing with the persistent pruritus and cutaneous inflammation characteristics of AD [9]. This evidence concerns the gene IL4R and Alzheimer disease.